PCR-based detection of Aspergillus fumigatus Cyp51A mutations on bronchoalveolar lavage: a multicentre validation of the AsperGenius assay ® in 201 patients with haematological disease suspected for invasive aspergillosis
Author(s) -
GaLai M. Chong,
Martha T. van der Beek,
Peter A. von dem Borne,
Jerina Boelens,
Eva Steel,
Greetje A. Kampinga,
Lambert F. R. Span,
Katrien Lagrou,
Johan Maertens,
Gijs Dingemans,
Giel R. Gaajetaan,
Dennis W. E. van Tegelen,
Jan J. Cornelissen,
Alieke G. Vonk,
Bart Rijnders
Publication year - 2016
Publication title -
journal of antimicrobial chemotherapy
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.124
H-Index - 194
eISSN - 1460-2091
pISSN - 0305-7453
DOI - 10.1093/jac/dkw323
Subject(s) - bronchoalveolar lavage , aspergillus fumigatus , aspergillosis , galactomannan , aspergillus , voriconazole , medicine , gastroenterology , azole , immunology , microbiology and biotechnology , biology , lung , antifungal
In patients with invasive aspergillosis (IA), fungal cultures are mostly negative. Consequently, azole resistance often remains undetected. The AsperGenius ® multiplex real-time PCR assay identifies clinically relevant Aspergillus species and four resistance-associated mutations (RAMs; TR34/L98H/T289A/Y121F) in the Cyp51A gene. This multicentre study evaluated the diagnostic performance of this assay on bronchoalveolar lavage (BAL) fluid and correlated the presence of RAMs with azole treatment failure and mortality.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom